Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Villamil-Ortiz, Javier Gustavoa | Barrera-Ocampo, Alvaroa | Arias-Londoño, Julián Davidb | Villegas, Andrésc | Lopera, Franciscoc | Cardona-Gómez, Gloria Patriciaa; *
Affiliations: [a] Cellular and Molecular Neurobiology Area, Group of Neuroscience, School of Medicine, SIU, University of Antioquia UdeA, Medellín, Colombia | [b] Department of Systems Engineering, University of Antioquia UdeA, Medellín, Colombia | [c] Neurobank, Group of Neuroscience, SIU, University of Antioquia, Medellín, Colombia
Correspondence: [*] Correspondence to: Gloria Patricia Cardona-Gómez, Universidad de Antioquia, Sede de Investigación Universitaria (SIU), Calle 62 No. 52 –59, Torre 1, Piso 4, Laboratorio 412, Medellín, Colombia. Tel.: +57 4 2196458; Fax: +57 4 2196444; E-mail: patricia.cardonag@udea.edu.co.
Abstract: Lipids are considered important factors in the pathogenesis of Alzheimer’s disease (AD). In this study, we realized a comparative analysis of the phospholipid profile and phospholipid composition of the temporal cortex from E280A-familiar AD (FAD), sporadic AD (SAD), and healthy human brains. Findings showed a significant decrease of lysophosphatidylcholine and phosphatidylethanolamine formed by low levels of polyunsaturated fatty acids (20 : 4, 22 : 6) in AD brains. However, phosphatidylethanolamine-ceramide and phosphoglycerol were significantly increased in SAD, conformed by high levels of (18 : 0/18 : 1) and (30/32/36 : 0/1/2), respectively. Together, the findings suggest a deficiency in lysophosphacholine and phosphatidylethanolamine, and alteration in the balance between poly- and unsaturated fatty acids in both types of AD, and a differential pattern of phospholipid profile and fatty acid composition between E280A FAD and SAD human brains.
Keywords: Alzheimer’s disease, phospholipids, fatty acids, temporal cortex, polyunsaturated fatty acids
DOI: 10.3233/JAD-170554
Journal: Journal of Alzheimer's Disease, vol. 61, no. 1, pp. 209-219, 2018
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
sales@iospress.com
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
info@iospress.nl
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office info@iospress.nl
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
china@iospress.cn
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
如果您在出版方面需要帮助或有任何建, 件至: editorial@iospress.nl